OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!
If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.
Requested Article:
Targeting the Microenvironment in Esophageal Cancer
Lei Wang, Huiqiong Han, Zehua Wang, et al.
Frontiers in Cell and Developmental Biology (2021) Vol. 9
Open Access | Times Cited: 24
Lei Wang, Huiqiong Han, Zehua Wang, et al.
Frontiers in Cell and Developmental Biology (2021) Vol. 9
Open Access | Times Cited: 24
Showing 24 citing articles:
Advancing Esophageal Cancer Treatment: Immunotherapy in Neoadjuvant and Adjuvant Settings
Daniel Park, Won Jin Jeon, Chieh Yang, et al.
Cancers (2024) Vol. 16, Iss. 2, pp. 318-318
Open Access | Times Cited: 10
Daniel Park, Won Jin Jeon, Chieh Yang, et al.
Cancers (2024) Vol. 16, Iss. 2, pp. 318-318
Open Access | Times Cited: 10
Mechanisms of tumor immunosuppressive microenvironment formation in esophageal cancer
Xiaojun Zhang, Yan Yu, Heping Zhao, et al.
World Journal of Gastroenterology (2024) Vol. 30, Iss. 16, pp. 2195-2208
Open Access | Times Cited: 5
Xiaojun Zhang, Yan Yu, Heping Zhao, et al.
World Journal of Gastroenterology (2024) Vol. 30, Iss. 16, pp. 2195-2208
Open Access | Times Cited: 5
The Role of Tumor Microenvironment in Invasion and Metastasis of Esophageal Squamous Cell Carcinoma
Shuyue Zheng, Beilei Liu, Xin‐Yuan Guan
Frontiers in Oncology (2022) Vol. 12
Open Access | Times Cited: 19
Shuyue Zheng, Beilei Liu, Xin‐Yuan Guan
Frontiers in Oncology (2022) Vol. 12
Open Access | Times Cited: 19
Therapeutic implications of signaling pathways and tumor microenvironment interactions in esophageal cancer
Inamu Rashid Khan, Hana Q. Sadida, Sheema Hashem, et al.
Biomedicine & Pharmacotherapy (2024) Vol. 176, pp. 116873-116873
Open Access | Times Cited: 3
Inamu Rashid Khan, Hana Q. Sadida, Sheema Hashem, et al.
Biomedicine & Pharmacotherapy (2024) Vol. 176, pp. 116873-116873
Open Access | Times Cited: 3
Association between preoperative neutrophil-to-lymphocyte ratio and the survival outcomes of esophageal cancer patients underwent esophagectomy: a systematic review and meta-analysis
Xun Wu, SiJie Liu, F.X. Li, et al.
Frontiers in Oncology (2024) Vol. 14
Open Access | Times Cited: 2
Xun Wu, SiJie Liu, F.X. Li, et al.
Frontiers in Oncology (2024) Vol. 14
Open Access | Times Cited: 2
IGFBP7 remodels the tumor microenvironment of esophageal squamous cell carcinoma by activating the TGFβ1/SMAD signaling pathway
Xiu‐Qing Li, Ji Zhang, Youshan Wu, et al.
Oncology Letters (2022) Vol. 24, Iss. 2
Open Access | Times Cited: 10
Xiu‐Qing Li, Ji Zhang, Youshan Wu, et al.
Oncology Letters (2022) Vol. 24, Iss. 2
Open Access | Times Cited: 10
Visfatin upregulates VEGF-C expression and lymphangiogenesis in esophageal cancer by activating MEK1/2-ERK and NF-κB signaling
Chang‐Lun Huang, David Achudhan, Po‐I Liu, et al.
Aging (2023)
Open Access | Times Cited: 5
Chang‐Lun Huang, David Achudhan, Po‐I Liu, et al.
Aging (2023)
Open Access | Times Cited: 5
Navigating Tumour Microenvironment and Wnt Signalling Crosstalk: Implications for Advanced Cancer Therapeutics
Shraddha Shravani Peri, Krithicaa Narayanaa Y., T. Hubert, et al.
Cancers (2023) Vol. 15, Iss. 24, pp. 5847-5847
Open Access | Times Cited: 4
Shraddha Shravani Peri, Krithicaa Narayanaa Y., T. Hubert, et al.
Cancers (2023) Vol. 15, Iss. 24, pp. 5847-5847
Open Access | Times Cited: 4
DNMT1-mediated epigenetic suppression of FBXO32 expression promoting cyclin dependent kinase 9 (CDK9) survival and esophageal cancer cell growth
Xian-Qiang Song, Binbin Chen, Yongmei Jin, et al.
Cell Cycle (2024) Vol. 23, Iss. 3, pp. 262-278
Closed Access | Times Cited: 1
Xian-Qiang Song, Binbin Chen, Yongmei Jin, et al.
Cell Cycle (2024) Vol. 23, Iss. 3, pp. 262-278
Closed Access | Times Cited: 1
Advancements in the research of immune checkpoint inhibitors for the treatment of advanced esophageal squamous cell carcinoma
Mengfei Sun
American Journal of Cancer Research (2024) Vol. 14, Iss. 5, pp. 1981-1998
Open Access | Times Cited: 1
Mengfei Sun
American Journal of Cancer Research (2024) Vol. 14, Iss. 5, pp. 1981-1998
Open Access | Times Cited: 1
Lysophosphatidic acid promotes ESCC progression by increasing the level of CCL2 secreted by esophageal epithelial cells
Hui Ma, Xiaoqian Ma, Lingyu Qi, et al.
The Journal of Gene Medicine (2024) Vol. 26, Iss. 6
Closed Access | Times Cited: 1
Hui Ma, Xiaoqian Ma, Lingyu Qi, et al.
The Journal of Gene Medicine (2024) Vol. 26, Iss. 6
Closed Access | Times Cited: 1
GABRP inhibits the progression of oesophageal cancer by regulating CFTR: Integrating bioinformatics analysis and experimental validation
Jingzhi Zhang, Xue Liu, Ling Zeng, et al.
International Journal of Experimental Pathology (2024) Vol. 105, Iss. 4, pp. 118-132
Closed Access | Times Cited: 1
Jingzhi Zhang, Xue Liu, Ling Zeng, et al.
International Journal of Experimental Pathology (2024) Vol. 105, Iss. 4, pp. 118-132
Closed Access | Times Cited: 1
Sitravatinib combined with PD-1 blockade enhances cytotoxic T-cell infiltration by M2 to M1 tumor macrophage repolarization in esophageal adenocarcinoma
Ryan Sweeney, Ashten N. Omstead, John T. Fitzpatrick, et al.
Carcinogenesis (2023) Vol. 45, Iss. 4, pp. 210-219
Closed Access | Times Cited: 2
Ryan Sweeney, Ashten N. Omstead, John T. Fitzpatrick, et al.
Carcinogenesis (2023) Vol. 45, Iss. 4, pp. 210-219
Closed Access | Times Cited: 2
LncRNA SSTR5-AS1 promotes esophageal carcinoma through regulating ITGB6/JAK1/STAT3 signaling
Zhaohui Tang, Yongjun Jiang, Yuyu Zong, et al.
Epigenomics (2024) Vol. 16, Iss. 17, pp. 1133-1148
Closed Access
Zhaohui Tang, Yongjun Jiang, Yuyu Zong, et al.
Epigenomics (2024) Vol. 16, Iss. 17, pp. 1133-1148
Closed Access
Effect of the immune microenvironment on prognosis in oesophageal adenocarcinoma.
Dimitra Peristeri, Munir Tarazi, Patrick J. Casey, et al.
Best Practice & Research Clinical Gastroenterology (2024) Vol. 72, pp. 101954-101954
Closed Access
Dimitra Peristeri, Munir Tarazi, Patrick J. Casey, et al.
Best Practice & Research Clinical Gastroenterology (2024) Vol. 72, pp. 101954-101954
Closed Access
Experimental and Computational Studies Reveal Novel Interaction of Lymphocytes Antigen 6K to TGF-β Receptor Complex
Justyna Andrys‐Olek, Benson Chellakkan Selvanesan, Sheelu Varghese, et al.
International Journal of Molecular Sciences (2023) Vol. 24, Iss. 16, pp. 12779-12779
Open Access | Times Cited: 1
Justyna Andrys‐Olek, Benson Chellakkan Selvanesan, Sheelu Varghese, et al.
International Journal of Molecular Sciences (2023) Vol. 24, Iss. 16, pp. 12779-12779
Open Access | Times Cited: 1
MAIP1-Related Tumor Immune Infiltration: As a Potential Prognostic Biomarker for Esophageal Cancer
Xiaoyu He, Fu Gan, Yongjian Lin, et al.
Journal of Immunology Research (2022) Vol. 2022, pp. 1-11
Open Access | Times Cited: 2
Xiaoyu He, Fu Gan, Yongjian Lin, et al.
Journal of Immunology Research (2022) Vol. 2022, pp. 1-11
Open Access | Times Cited: 2
Novel Treatment Options in Metastatic Esophageal Carcinoma: Checkpoint Inhibitors in Combination Therapies
Capucine Casari, René Novysedlák, J Vachtenheim, et al.
Pharmacology (2022) Vol. 108, Iss. 1, pp. 37-46
Open Access | Times Cited: 2
Capucine Casari, René Novysedlák, J Vachtenheim, et al.
Pharmacology (2022) Vol. 108, Iss. 1, pp. 37-46
Open Access | Times Cited: 2
From NLR to TIN: What Can’t Neutrophils Tell Us About Prognosis in Resectable Esophageal Cancer?
Nathaniel Deboever, Wayne L. Hofstetter
Annals of Surgical Oncology (2023) Vol. 30, Iss. 3, pp. 1295-1296
Open Access
Nathaniel Deboever, Wayne L. Hofstetter
Annals of Surgical Oncology (2023) Vol. 30, Iss. 3, pp. 1295-1296
Open Access
Preliminary Exploration of the Clinical Features and Immunological Correlation between TIGIT and Esophageal Squamous Cell Carcinoma
Lei Shi, Zhongling Luo, Huanhuan Tian, et al.
Journal of Biosciences and Medicines (2023) Vol. 11, Iss. 04, pp. 350-362
Open Access
Lei Shi, Zhongling Luo, Huanhuan Tian, et al.
Journal of Biosciences and Medicines (2023) Vol. 11, Iss. 04, pp. 350-362
Open Access
Development and validation of a prognostic model for esophageal cancer patients with liver metastasis: a cohort study based on surveillance, epidemiology, and end results database
Xiaolong Wu, Xudong Zhang, Jingjing Ge, et al.
Journal of Cancer Research and Clinical Oncology (2023) Vol. 149, Iss. 15, pp. 13501-13510
Closed Access
Xiaolong Wu, Xudong Zhang, Jingjing Ge, et al.
Journal of Cancer Research and Clinical Oncology (2023) Vol. 149, Iss. 15, pp. 13501-13510
Closed Access
The role of FBXO32 in regulating the growth of esophageal cancer
Xian-qiang Song, Bin-bin Chen, Yong‐Mei Jin, et al.
Research Square (Research Square) (2023)
Open Access
Xian-qiang Song, Bin-bin Chen, Yong‐Mei Jin, et al.
Research Square (Research Square) (2023)
Open Access
Cell cycle-related FAM64A could be activated by TGF-β signaling to promote glioma progression
Minjie Fu, Jingwen Zhang, Yuan Feng, et al.
Research Square (Research Square) (2022)
Open Access
Minjie Fu, Jingwen Zhang, Yuan Feng, et al.
Research Square (Research Square) (2022)
Open Access
Development and validation of a nomogram for patients with stage II/III gastric adenocarcinoma after radical surgery
Lei Wang, Huiqiong Han, Liwen Feng, et al.
Frontiers in Surgery (2022) Vol. 9
Open Access
Lei Wang, Huiqiong Han, Liwen Feng, et al.
Frontiers in Surgery (2022) Vol. 9
Open Access
